A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Conditions:
Hypochondroplasia
Sponsor: BioMarin Pharmaceutical
trial.available_in:
БГ
Overview
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Who can participate
Inclusion Criteria:
* Participants must be ≤ 15 years old at the time of signing the informed consent
* Participants must have genetic confirmation of Hypochondroplasia diagnosis
Exclusion Criteria:
* Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
* Received an investigational product or medical device within 6 months before the Screening visit
Locations
11
Argentina (1)
Hospital de Pediatria SAMIC Prof. Dr. Juan P Garrahan
Buenos Aires
NOT_YET_RECRUITING
Australia (1)
Royal Children's Hospital Melbourne
Parkville , Victoria
Brazil (1)
Hospital de Clinicas de Porto Algre
Porto Alegre , Rio Grande Do Sol
NOT_YET_RECRUITING
Canada (1)
Stollery Children's Hospital
Edmonton , Alberta
France (1)
Hospices Civils de Lyon - Hôpital Femme Mère Enfant
Lyon
Germany (1)
Uniklinik Koln
Cologne
Italy (1)
Istituto Giannina Gaslini
Genoa , Liguria
Japan (1)
Kumamoto University Hospital
Kumamoto , Kumamoto
Spain (1)
Hospital Universitario La Paz
Madrid
United Kingdom (1)
Great Ormond Street Hospital for Children NHS Foundation Trust